Document_And_Entity_Informatio
Document And Entity Information | 9 Months Ended | |
Sep. 30, 2014 | Oct. 31, 2014 | |
Document and Entity Information [Abstract] | ' | ' |
Document Type | '10-Q | ' |
Amendment Flag | 'false | ' |
Document Period End Date | 30-Sep-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Entity Trading Symbol | 'RPXC | ' |
Entity Registrant Name | 'RPX Corporation | ' |
Entity Central Index Key | '0001509432 | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Filer Category | 'Accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 53,938,712 |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $83,326 | $100,155 |
Short-term investments | 219,804 | 190,567 |
Restricted cash | 660 | 364 |
Accounts receivable | 21,572 | 38,477 |
Prepaid expenses and other current assets | 17,381 | 10,546 |
Deferred tax assets | 4,136 | 3,817 |
Total current assets | 346,879 | 343,926 |
Patent assets, net | 248,051 | 219,954 |
Property and equipment, net | 4,214 | 4,667 |
Intangible assets, net | 3,962 | 1,718 |
Goodwill | 19,978 | 16,460 |
Restricted cash, less current portion | 1,091 | 1,454 |
Other assets | 785 | 622 |
Total assets | 624,960 | 588,801 |
Current liabilities: | ' | ' |
Accounts payable | 596 | 332 |
Accrued liabilities | 10,993 | 8,784 |
Deferred revenue | 110,874 | 131,808 |
Deferred payment obligations | 0 | 500 |
Other current liabilities | 13,316 | 1,638 |
Total current liabilities | 135,779 | 143,062 |
Deferred revenue, less current portion | 1,946 | 5,935 |
Deferred tax liabilities | 11,846 | 11,654 |
Other liabilities | 3,043 | 3,227 |
Total liabilities | 152,614 | 163,878 |
Commitments and contingencies (Note 12) | ' | ' |
Stockholders’ equity: | ' | ' |
Common stock | 5 | 5 |
Additional paid-in capital | 322,774 | 305,343 |
Retained earnings | 149,619 | 119,527 |
Accumulated other comprehensive income (loss) | -52 | 48 |
Total stockholders’ equity | 472,346 | 424,923 |
Total liabilities and stockholders’ equity | $624,960 | $588,801 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Operations (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Income Statement [Abstract] | ' | ' | ' | ' |
Revenue | $65,407 | $58,554 | $191,588 | $177,229 |
Cost of revenue | 30,444 | 29,766 | 90,906 | 78,130 |
Selling, general and administrative expenses | 17,786 | 15,584 | 53,620 | 45,793 |
(Gain) loss on sale of patent assets, net | -8 | 0 | -707 | 126 |
Operating income | 17,185 | 13,204 | 47,769 | 53,180 |
Other income, net | 73 | 56 | 266 | 170 |
Income before provision for income taxes | 17,258 | 13,260 | 48,035 | 53,350 |
Provision for income taxes | 6,425 | 4,863 | 17,943 | 19,561 |
Net income | 10,833 | 8,397 | 30,092 | 33,789 |
Net income available to common stockholders | $10,833 | $8,395 | $30,092 | $33,767 |
Net income available to common stockholders per common share: | ' | ' | ' | ' |
Basic (dollars per common share) | $0.20 | $0.16 | $0.56 | $0.65 |
Diluted (dollars per common share) | $0.20 | $0.16 | $0.55 | $0.63 |
Weighted-average shares used in computing net income available to common stockholders per common share: | ' | ' | ' | ' |
Basic (in shares) | 53,773 | 52,267 | 53,263 | 51,751 |
Diluted (in shares) | 55,029 | 54,055 | 54,742 | 53,415 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Income (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Statement of Comprehensive Income [Abstract] | ' | ' | ' | ' |
Net income | $10,833 | $8,397 | $30,092 | $33,789 |
Unrealized gains (losses) on available-for-sale securities: | ' | ' | ' | ' |
Unrealized holding gains (losses) arising during the period | -81 | 20 | -100 | 77 |
Less: reclassification adjustment for (gains) losses included in net income | 0 | 0 | 0 | 1 |
Net unrealized gains (losses) on available-for-sale securities, net of tax | -81 | 20 | -100 | 78 |
Comprehensive income | $10,752 | $8,417 | $29,992 | $33,867 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements of Cash Flows (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 |
Cash flows from operating activities | ' | ' |
Net income | $30,092 | $33,789 |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' |
Stock-based compensation | 89,700 | 76,767 |
Stock-based compensation | 13,353 | 12,081 |
Excess tax benefit from stock-based compensation | -2,394 | -2,752 |
(Gain) loss on sale of patent assets, net | -707 | 126 |
Amortization of premium on investments | 5,031 | 4,496 |
Deferred taxes | -1,797 | -2,772 |
Other | -500 | 13 |
Changes in assets and liabilities, net of business acquired: | ' | ' |
Accounts receivable | 17,227 | 5,259 |
Other receivables | 0 | 33,775 |
Prepaid expenses and other assets | -8,833 | -6,392 |
Accounts payable | 264 | 143 |
Accrued and other liabilities | 1,507 | 1,134 |
Deferred revenue | -25,023 | 859 |
Net cash provided by operating activities | 117,920 | 156,526 |
Cash flows from investing activities | ' | ' |
Purchases of investments classified as available-for-sale | -176,209 | -134,155 |
Maturities of investments classified as available-for-sale | 146,225 | 115,122 |
Sales of investments classified as available-for-sale | 0 | 1,099 |
Business acquisition, net of cash acquired | -2,286 | 0 |
Decrease in restricted cash | 67 | -1,818 |
Purchases of property and equipment | -1,084 | -2,073 |
Acquisitions of patent assets | -103,958 | -82,751 |
Proceeds from sale of patent assets | 1,086 | 100 |
Net cash used in investing activities | -136,159 | -104,476 |
Cash flows from financing activities | ' | ' |
Proceeds from exercise of stock options and other common stock issuances | 2,864 | 4,174 |
Taxes paid related to net-share settlements of restricted stock units | -3,848 | 0 |
Excess tax benefit from stock-based compensation | 2,394 | 2,752 |
Net cash provided by financing activities | 1,410 | 6,926 |
Net increase (decrease) in cash and cash equivalents | -16,829 | 58,976 |
Cash and cash equivalents at beginning of period | 100,155 | 73,638 |
Cash and cash equivalents at end of period | 83,326 | 132,614 |
Non-cash investing and financing activities | ' | ' |
Change in patent assets purchased and accrued but not paid | 11,700 | 3,400 |
Change in fixed assets purchased and accrued but not paid | -166 | 681 |
Change in other assets purchased and accrued but not paid | -63 | 500 |
Unpaid cash consideration for business acquisition | $425 | $0 |
Nature_of_Business
Nature of Business | 9 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Nature Of Business | ' |
Nature of Business | |
RPX Corporation (also referred to herein as “RPX” or the “Company”) helps companies reduce patent-related risk and expense by providing a subscription-based patent risk management solution that facilitates more efficient exchanges of value between owners and users of patents compared to transactions driven by actual or threatened litigation. The core of the Company’s solution is defensive patent aggregation, in which it acquires patents or licenses to patents that are being or may be asserted against the Company’s current or prospective clients. The Company may occasionally enter into agreements to acquire covenants not to sue in order to further mitigate its clients’ litigation risk. The acquired patents, licenses to patents, patent rights and agreements for covenants not to sue are collectively referred to as “patent assets.” The Company’s clients pay an annual subscription fee and in return, receive a license from the Company to substantially all of its patent assets and access to its proprietary patent market intelligence and data. In addition to the Company’s core solution, in August 2012, the Company began underwriting patent infringement liability insurance policies to insure against certain costs of litigation from non-practicing entities (“NPEs”). In March 2014, the Company formed a reinsurance company to assume some portion of the underwriting risk on insurance policies that the Company issues on behalf of a Lloyd’s of London underwriting syndicate. The Company began placing new policies under the reinsurance model in May 2014. As of, and for the three and nine months ended September 30, 2014, the effect of the insurance policies that the Company has issued or assumed through our reinsurance business was not material to the Company’s results of operations, financial condition or cash flows. |
Basis_of_Presentation_and_Sign
Basis of Presentation and Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2014 | |
Accounting Policies [Abstract] | ' |
Basis Of Presentation And Significant Accounting Policies | ' |
Basis of Presentation and Significant Accounting Policies | |
Basis of Presentation | |
The accompanying condensed consolidated balance sheet as of September 30, 2014, the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2014 and 2013, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2014 and 2013, are unaudited. The condensed consolidated balance sheet as of December 31, 2013 was derived from the audited consolidated financial statements which are included in the Company’s Form 10-K for the fiscal year ended December 31, 2013, which was filed with the U.S. Securities and Exchange Commission (“SEC”) on March 10, 2014. The unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. | |
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and with the instructions for Form 10-Q and Regulation S-X for interim financial statements. Accordingly, they do not include all of the information and notes required for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring items, necessary to state fairly the results of the interim periods have been included in the accompanying financial statements. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for any subsequent interim period or for the year ending December 31, 2014. | |
There have been no material changes to the Company’s significant accounting policies during the three and nine months ended September 30, 2014, as compared to the significant accounting policies presented under the heading “Basis of Presentation and Significant Accounting Policies” in Note 2 of the Notes to Consolidated Financial Statements in Part II, Item 8 of the Company’s Annual Report on Form 10-K filed with the SEC on March 10, 2014. | |
Recently Issued Accounting Standards | |
In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern ("ASU 2014-15") provides new guidance related to management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards and to provide related footnote disclosures. This new guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter; early adoption is permitted. The requirements of ASU 2014-15 are not expected to have a significant impact on the condensed consolidated financial statements. | |
In June 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (“ASU 2014-12”), which amends Compensation - Stock Compensation (Topic 718) in the Accounting Standards Codification (“ASC”). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Compensation - Stock Compensation (Topic 718) as it relates to awards with performance conditions that affect vesting to account for such awards. The amendments in ASU 2014-12 will be effective for annual and interim periods beginning after December 15, 2015 and early adoption is permitted. The adoption of ASU 2014-12 is not expected to have a material impact on the Company’s consolidated financial statements. | |
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which will supersede most existing revenue recognition guidance in U.S. generally accepted accounting principles (“U.S. GAAP”) once it becomes effective. ASU 2014-09 requires an entity to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 will be effective for annual and interim periods beginning after December 15, 2016 and early adoption is not permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-12 on its consolidated financial statements. | |
In April 2014, the FASB issued ASU 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360) (“ASU 2014-08”), which amends the requirements for reporting discontinued operations and enhances disclosure requirements. The amendments in ASU 2014-08 will be effective for all disposals (or classifications as held for sale) of components of an entity beginning on or after December 15, 2014 and early adoption is permitted. The adoption of ASU 2014-08 is not expected to have a material impact on the Company’s consolidated financial statements. |
Net_Income_Available_to_Common
Net Income Available to Common Stockholders | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Net Income Available to Common Stockholders | ' | |||||||||||||||
Net Income Available to Common Stockholders | ||||||||||||||||
Basic and diluted net income per share available to common stockholders are presented in conformity with the two-class method required for participating securities. The holders of restricted common stock are entitled to receive non-forfeitable dividends if declared. | ||||||||||||||||
Under the two-class method, basic net income per share available to common stockholders is computed by dividing the net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Net income available to common stockholders is determined by allocating undistributed earnings between common and restricted common stockholders. Diluted net income per share available to common stockholders is computed by using the weighted-average number of shares of common stock outstanding, including potential dilutive shares of common stock, assuming the dilutive effect of outstanding stock options and restricted stock units using the treasury stock method. | ||||||||||||||||
The following table presents the calculation of basic and diluted net income per share available to common stockholders (in thousands, except per share data): | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Net income available to common stockholders: | ||||||||||||||||
Numerator: | ||||||||||||||||
Net income | $ | 10,833 | $ | 8,397 | $ | 30,092 | $ | 33,789 | ||||||||
Allocation of net income to participating stockholders | — | (2 | ) | — | (22 | ) | ||||||||||
Net income available to common stockholders | $ | 10,833 | $ | 8,395 | $ | 30,092 | $ | 33,767 | ||||||||
Denominator: | ||||||||||||||||
Basic shares: | ||||||||||||||||
Weighted-average shares used in computing basic net income available to common stockholders | 53,773 | 52,267 | 53,263 | 51,751 | ||||||||||||
Diluted shares: | ||||||||||||||||
Weighted-average shares used in computing basic net income available to common stockholders | 53,773 | 52,267 | 53,263 | 51,751 | ||||||||||||
Dilutive effect of stock options and restricted stock units using the treasury-stock method | 1,256 | 1,788 | 1,479 | 1,664 | ||||||||||||
Weighted-average shares used in computing diluted net income available to common stockholders | 55,029 | 54,055 | 54,742 | 53,415 | ||||||||||||
Net income per common share available to common stockholders: | ||||||||||||||||
Basic | $ | 0.2 | $ | 0.16 | $ | 0.56 | $ | 0.65 | ||||||||
Diluted | $ | 0.2 | $ | 0.16 | $ | 0.55 | $ | 0.63 | ||||||||
The following securities were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive (in thousands): | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Weighted-average: | ||||||||||||||||
Stock options outstanding | 763 | 1,059 | 749 | 1,360 | ||||||||||||
Restricted stock units outstanding | 245 | 143 | 30 | 255 | ||||||||||||
Shares of common stock subject to repurchase | — | 13 | — | 34 | ||||||||||||
Fair_Value_Measurements
Fair Value Measurements | 9 Months Ended | |||||||||||
Sep. 30, 2014 | ||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||
Fair Value Measurements | ' | |||||||||||
Fair Value Measurements | ||||||||||||
The following tables present the Company’s financial assets measured at fair value on a recurring basis (in thousands): | ||||||||||||
September 30, 2014 | ||||||||||||
Fair Value | Level 1 | Level 2 | ||||||||||
Cash equivalents: | ||||||||||||
Commercial paper | $ | 24,179 | $ | — | $ | 24,179 | ||||||
Money market funds | 1,026 | 1,026 | — | |||||||||
Municipal bonds | 4,057 | — | 4,057 | |||||||||
$ | 29,262 | $ | 1,026 | $ | 28,236 | |||||||
Short-term investments: | ||||||||||||
Municipal bonds | $ | 127,562 | $ | — | $ | 127,562 | ||||||
Corporate bonds | 56,070 | — | 56,070 | |||||||||
Commercial paper | 2,497 | — | 2,497 | |||||||||
U.S. government and agency securities | 33,675 | — | 33,675 | |||||||||
$ | 219,804 | $ | — | $ | 219,804 | |||||||
December 31, 2013 | ||||||||||||
Fair Value | Level 1 | Level 2 | ||||||||||
Cash equivalents: | ||||||||||||
Commercial paper | $ | 34,498 | $ | — | $ | 34,498 | ||||||
U.S. government and agency securities | 3,801 | — | 3,801 | |||||||||
Money market funds | 37 | 37 | — | |||||||||
$ | 38,336 | $ | 37 | $ | 38,299 | |||||||
Short-term investments: | ||||||||||||
Municipal bonds | $ | 146,100 | $ | — | $ | 146,100 | ||||||
Commercial paper | 31,597 | — | 31,597 | |||||||||
Corporate bonds | 7,875 | — | 7,875 | |||||||||
U.S. government and agency securities | 4,995 | — | 4,995 | |||||||||
$ | 190,567 | $ | — | $ | 190,567 | |||||||
As of September 30, 2014 and December 31, 2013, the Company did not use Level 3 inputs to measure financial assets or liabilities at fair value. |
Shortterm_Investments
Short-term Investments | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Short-term Investments [Abstract] | ' | |||||||||||||||
Short-term Investments | ' | |||||||||||||||
Short-term Investments | ||||||||||||||||
The following tables present the Company’s investments in available-for-sale securities (in thousands): | ||||||||||||||||
September 30, 2014 | ||||||||||||||||
Unrealized | ||||||||||||||||
Amortized Cost | Gains | Losses | Estimated Fair Value | |||||||||||||
Municipal bonds | $ | 127,516 | $ | 52 | $ | (6 | ) | $ | 127,562 | |||||||
Corporate bonds | 56,150 | 2 | (82 | ) | 56,070 | |||||||||||
Commercial paper | 2,497 | — | — | 2,497 | ||||||||||||
U.S. government and agency securities | 33,693 | 4 | (22 | ) | 33,675 | |||||||||||
$ | 219,856 | $ | 58 | $ | (110 | ) | $ | 219,804 | ||||||||
December 31, 2013 | ||||||||||||||||
Unrealized | ||||||||||||||||
Amortized Cost | Gains | Losses | Estimated Fair Value | |||||||||||||
Municipal bonds | $ | 146,047 | $ | 56 | $ | (3 | ) | $ | 146,100 | |||||||
Commercial paper | 31,597 | — | — | 31,597 | ||||||||||||
Corporate bonds | 7,873 | 2 | — | 7,875 | ||||||||||||
U.S. government and agency securities | 5,002 | — | (7 | ) | 4,995 | |||||||||||
$ | 190,519 | $ | 58 | $ | (10 | ) | $ | 190,567 | ||||||||
Available-for-sale securities are reported at fair value, with unrealized gains and losses, net of tax, included as a separate component of stockholders’ equity within accumulated other comprehensive income (loss). Realized gains and losses on available-for-sale securities are included in other income, net in the Company’s condensed consolidated statements of operations and have not been material for all periods presented. | ||||||||||||||||
The weighted-average remaining maturity of the Company’s investment portfolio was less than one year as of September 30, 2014 and December 31, 2013. As of September 30, 2014, no individual securities incurred continuous unrealized losses for greater than 12 months. |
Patent_Assets_Net
Patent Assets, Net | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Patent Assets, Net [Abstract] | ' | |||||||||||||||
Patent Assets, Net | ' | |||||||||||||||
Patent Assets, Net | ||||||||||||||||
Patent assets, net, consisted of the following (in thousands): | ||||||||||||||||
December 31, | Additions | Sales | September 30, | |||||||||||||
2013 | 2014 | |||||||||||||||
Patent assets | $ | 529,526 | $ | 115,658 | $ | (705 | ) | $ | 644,479 | |||||||
Accumulated amortization | (309,572 | ) | (87,181 | ) | 325 | (396,428 | ) | |||||||||
Patent assets, net | $ | 219,954 | $ | 248,051 | ||||||||||||
The Company’s acquired patent assets relate to technologies used or supplied by companies in a variety of market sectors, including consumer electronics, e-commerce, financial services, media distribution, mobile communications, networking, semiconductors and software. The Company amortizes each acquired portfolio of patent assets on a straight-line basis over its estimated economic useful life. As of September 30, 2014, the estimated economic useful lives of the Company’s patent assets generally ranged from 24 to 60 months. As of September 30, 2014, the weighted-average estimated economic useful life at the time of acquisition of all patents acquired since the Company’s inception was 46 months. | ||||||||||||||||
As of September 30, 2014, the Company expects amortization expense in future periods to be as follows (in thousands): | ||||||||||||||||
2014 (remainder) | $ | 31,371 | ||||||||||||||
2015 | 103,961 | |||||||||||||||
2016 | 73,434 | |||||||||||||||
2017 | 31,714 | |||||||||||||||
2018 | 6,788 | |||||||||||||||
Thereafter | 783 | |||||||||||||||
Total estimated future amortization expense | $ | 248,051 | ||||||||||||||
Amortization expense was $29.5 million and $28.2 million for the three months ended September 30, 2014 and 2013, respectively, and $87.2 million and $74.5 million for the nine months ended September 30, 2014 and 2013, respectively. |
Property_and_Equipment_Net
Property and Equipment, Net | 9 Months Ended | |||||||
Sep. 30, 2014 | ||||||||
Property, Plant and Equipment, Net, by Type [Abstract] | ' | |||||||
Property and Equipment, Net | ' | |||||||
Property and Equipment, Net | ||||||||
Property and equipment, net, consisted of the following (in thousands): | ||||||||
September 30, | December 31, | |||||||
2014 | 2013 | |||||||
Internal-use software | $ | 4,931 | $ | 4,198 | ||||
Leasehold improvements | 1,799 | 1,700 | ||||||
Computer, equipment and software | 1,207 | 1,096 | ||||||
Furniture and fixtures | 818 | 813 | ||||||
Construction-in-progress | 181 | 119 | ||||||
Total property and equipment, gross | 8,936 | 7,926 | ||||||
Less: Accumulated depreciation and amortization | (4,722 | ) | (3,259 | ) | ||||
Total property and equipment, net | $ | 4,214 | $ | 4,667 | ||||
Depreciation and amortization expense was $0.5 million and $0.4 million for the three months ended September 30, 2014 and 2013, respectively, and $1.5 million and $1.2 million for the nine months ended September 30, 2014 and 2013, respectively. Stock-based compensation capitalized as part of the cost of internal-use software was nil for both the three months ended September 30, 2014 and 2013, respectively, and $0.1 million and nil for the nine months ended September 30, 2014 and 2013, respectively. |
Business_Combinations
Business Combinations | 9 Months Ended |
Sep. 30, 2014 | |
Business Combinations [Abstract] | ' |
Business Combinations | ' |
Business Combinations | |
On June 19, 2014, the Company completed its acquisition of all of the issued and outstanding membership interests in DCML Services Corporation (“DCML”), a provider of data, intelligence and consulting on NPEs (operating under the trade name PatentFreedom). The final purchase price for DCML was approximately $6.2 million, consisting of $3.0 million in cash and 182,408 shares of the Company’s common stock. The fair value of the equity component of the final purchase price of $3.2 million was determined for accounting purposes based on the fair value of the Company’s common stock on the closing date of the acquisition. As of September 30, 2014, the Company has paid $2.6 million of the cash consideration. The shares of common stock were issued in July 2014 and are restricted pursuant to the terms of the agreement. The Company recorded $3.3 million of intangible assets which includes a covenant not to compete, proprietary data and customer relationships, $1.1 million in net deferred tax liabilities, $0.5 million in net tangible assets, and $3.5 million of residual goodwill. The covenant not to compete and proprietary data and customer relationships are being amortized over a weighted-average estimated economic useful life of 3 years. The goodwill recorded pertains to the cost benefits and operational synergies realized by integrating DCML’s data with the Company’s proprietary database that cross-references all patent, litigation and entity information. The goodwill is not expected to be deductible for tax purposes. For the nine months ended September 30, 2014, the Company recorded acquisition-related costs of $0.1 million which were expensed as incurred and included in the Company's selling, general and administrative expenses. The Company has included the financial results of DCML in its condensed consolidated financial statements from the acquisition date and the results are not individually material to its condensed consolidated financial statements. |
Goodwill
Goodwill | 9 Months Ended | |||
Sep. 30, 2014 | ||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||
Goodwill | ' | |||
Goodwill | ||||
The changes in the carrying amounts of goodwill were as follows (in thousands): | ||||
Balance as of December 31, 2013 | $ | 16,460 | ||
Goodwill from business acquisition | 3,518 | |||
Balance as of September 30, 2014 | $ | 19,978 | ||
We review goodwill for impairment at least annually on September 30 or more frequently if events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. We have elected to first assess the qualitative factors to determine whether it is more likely than not that the fair value of our single reporting operating unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment under ASU No. 2011-08, Goodwill and Other (Topic 350): Testing Goodwill for Impairment, issued by the FASB. If we determine that it is more likely than not that its fair value is less than its carrying amount, then the two-step goodwill impairment test will be performed. The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step will be performed; otherwise, no further step is required. The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill. Any excess of the goodwill carrying amount over the applied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value. As of September 30, 2014, the date of the Company's 2014 assessment, no impairment of goodwill has been identified. |
Intangible_Assets_Net
Intangible Assets, Net | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' | |||||||||||||||||||||||
Intangible Assets, Net | ' | |||||||||||||||||||||||
Intangible Assets, Net | ||||||||||||||||||||||||
Intangible assets, net, consisted of the following (in thousands): | ||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||||||||||||
Carrying Amount | Accumulated Amortization | Net Carrying Amount | Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||||||
Covenant not to compete | $ | 1,920 | $ | (199 | ) | $ | 1,721 | $ | 480 | $ | (469 | ) | $ | 11 | ||||||||||
Proprietary data and models | 2,100 | (975 | ) | 1,125 | 1,500 | (637 | ) | 863 | ||||||||||||||||
Customer relationships | 1,050 | (326 | ) | 724 | 250 | (215 | ) | 35 | ||||||||||||||||
Trademarks | 1,890 | (1,503 | ) | 387 | 1,890 | (1,184 | ) | 706 | ||||||||||||||||
Developed technology | 728 | (723 | ) | 5 | 728 | (625 | ) | 103 | ||||||||||||||||
$ | 7,688 | $ | (3,726 | ) | $ | 3,962 | $ | 4,848 | $ | (3,130 | ) | $ | 1,718 | |||||||||||
As of September 30, 2014, the Company expects amortization expense in future periods to be as follows (in thousands): | ||||||||||||||||||||||||
2014 (remainder) | $ | 437 | ||||||||||||||||||||||
2015 | 1,725 | |||||||||||||||||||||||
2016 | 1,288 | |||||||||||||||||||||||
2017 | 512 | |||||||||||||||||||||||
Total estimated future amortization expense | $ | 3,962 | ||||||||||||||||||||||
Amortization expense was $0.5 million and $0.3 million for the three months ended September 30, 2014 and 2013, respectively, and $1.1 million for both the nine months ended September 30, 2014 and 2013, respectively. |
Accrued_and_Other_Current_Liab
Accrued and Other Current Liabilities | 9 Months Ended | |||||||
Sep. 30, 2014 | ||||||||
Payables and Accruals [Abstract] | ' | |||||||
Accrued And Other Current Liabilities | ' | |||||||
Accrued and Other Current Liabilities | ||||||||
Accrued and other current liabilities consisted of the following (in thousands): | ||||||||
September 30, | December 31, | |||||||
2014 | 2013 | |||||||
Accrued payroll-related expenses | $ | 7,579 | $ | 6,791 | ||||
Accrued expenses | 3,414 | 1,993 | ||||||
Total accrued liabilities | $ | 10,993 | $ | 8,784 | ||||
Other current liabilities | $ | 691 | $ | 1,075 | ||||
Consideration payable for business acquisition | 425 | — | ||||||
Patent and other assets purchased but not paid | 12,200 | 563 | ||||||
Total other current liabilities | $ | 13,316 | $ | 1,638 | ||||
Commitments_and_Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Commitments And Contingencies | ' |
Commitments and Contingencies | |
Operating Lease Commitments | |
The Company generally does not enter into long-term minimum purchase commitments. Its principal long-term commitments consist of obligations under operating leases for office space. There were no substantial changes to the Company’s contractual obligations or commitments during the nine months ended September 30, 2014 as compared to those presented under the heading “Commitments and Contingencies” in Note 12 of the Notes to Consolidated Financial Statements in Part II, Item 8 of the Company’s Annual Report on Form 10-K filed with the SEC on March 10, 2014. | |
Rent expense related to non-cancelable operating leases was $0.9 million and $1.1 million for the three months ended September 30, 2014 and 2013, respectively, net of sublease income of $0.2 million and nil, respectively. Rent expense related to non-cancelable operating leases was $2.7 million and $2.5 million for the nine months ended September 30, 2014 and 2013, respectively, net of sublease income of $0.4 million and nil, respectively. | |
Litigation | |
From time to time, the Company may be a party to various litigation claims in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation or contingencies. A liability is recorded when and if it is determined that such a liability for litigation or contingencies is both probable and reasonably estimable. No liability for litigation or contingencies was recorded as of September 30, 2014 or December 31, 2013. | |
In June 2013, Kevin O’Halloran, as Trustee of the Liquidating Trust of Teltronics, Inc. (the “Debtor”), filed a complaint in the U.S. Bankruptcy Court for the Middle District of Florida against the Company and Harris Corporation (the “Defendants”). The complaint alleges that the Defendants are liable under federal and state bankruptcy law regarding fraudulent transfers for the value of a patent portfolio purchased by the Company from Harris Corporation pursuant to an agreement entered into in January 2009, and within four years of the date the Debtor filed its petition in bankruptcy. The Company is not currently able to determine whether there is a reasonable possibility that a loss has been incurred, nor can it estimate the potential loss or range of the potential loss that may result from this litigation. | |
In March 2012, Cascades Computer Innovations LLC filed a complaint in U.S. District Court for the Northern District of California (the “Court”) against the Company and five of its clients (collectively the “Defendants”). The complaint alleges that the Defendants violated federal antitrust law, California antitrust law and California unfair competition law. The complaint further alleges that after the Company terminated its negotiations with the plaintiff to license certain patents held by the plaintiff, the Defendants violated the law by jointly refusing to negotiate or accept licenses under the plaintiff’s patents. The plaintiff seeks unspecified monetary damages and injunctive relief. In January 2013, the Court dismissed the complaint against the Defendants and granted the plaintiff leave to amend its complaint. In February 2013, the plaintiff filed an amended lawsuit alleging that the Defendants violated federal antitrust law, California antitrust law and California unfair competition law. In March 2014, the Court entered an order staying the litigation pending the resolution of related litigation in the U.S. District Court for the Northern District of Illinois, and in July 2014 and again in September 2014 continued the stay. The Company is not currently able to determine whether there is a reasonable possibility that a loss has been incurred, nor can it estimate the potential loss or range of the potential loss that may result from this litigation. | |
Guarantees and Indemnifications | |
The Company has, in connection with the sale of patent assets, agreed to indemnify and hold harmless the buyer of such patent assets for losses resulting from breaches of representations and warranties made by the Company. The terms of these indemnification agreements are generally perpetual. The maximum amount of potential future indemnification is unlimited. To date, the Company has not paid any amount to settle claims or defend lawsuits. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. The Company had no liabilities recorded for these agreements as of September 30, 2014 or December 31, 2013. The Company has no reason to believe that there is any material liability related to such indemnification provisions. The Company does not indemnify its clients for patent infringement. | |
In accordance with its amended and restated bylaws, the Company also indemnifies certain officers and employees for losses incurred in connection with actions, suits or proceedings threatened or brought against such officer or employee arising from his or her service to the Company as an officer or employee, subject to certain limitations. The term of the indemnification period is indefinite. The maximum amount of potential future indemnification is unspecified. The Company has no reason to believe that there is any material liability for actions, events or occurrences that have occurred to date. | |
Reserves for Known and Incurred but not Reported Claims | |
In August 2012, the Company began offering insurance to cover certain costs of litigation brought against its insured clients by NPEs. As of September 30, 2014, the Company had a total of 38 active policies and had recorded a reserve of $1.6 million for known and incurred but not reported claims that represent estimated claim costs and related expenses. | |
The Company regularly reviews its loss reserves using a variety of actuarial techniques and updates them as its loss experience develops. |
Stockholders_Equity
Stockholders' Equity | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Stockholders Equity and Share-based Compensation [Abstract] | ' | |||||||||||||||
Stockholders' Equity | ' | |||||||||||||||
Stockholders’ Equity | ||||||||||||||||
Equity Plans | ||||||||||||||||
A summary of the Company’s activity under its equity-settled award plans and related information is as follows (in thousands, except per share data): | ||||||||||||||||
Options Outstanding | ||||||||||||||||
Shares Available for Grant | Number of Shares | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Life in Years | Aggregate Intrinsic Value | ||||||||||||
Balance - December 31, 2013 | 2,451 | 4,089 | $ | 9.91 | ||||||||||||
Shares authorized(1) | 1,000 | — | — | |||||||||||||
Options exercised | — | (561 | ) | 5.11 | ||||||||||||
Options forfeited/canceled | 173 | (173 | ) | 17.51 | ||||||||||||
Restricted stock units granted | (1,416 | ) | — | — | ||||||||||||
Restricted stock units forfeited | 238 | — | — | |||||||||||||
Restricted stock units withheld related to net-share settlement of restricted stock units | 244 | — | — | |||||||||||||
Balance - September 30, 2014 | 2,690 | 3,355 | 10.32 | 6.4 | $ | 14,912 | ||||||||||
Vested and exercisable - September 30, 2014 | 2,360 | 10.47 | 6.3 | 10,706 | ||||||||||||
Vested and expected to vest - September 30, 2014 | 3,237 | 10.34 | 6.4 | 14,397 | ||||||||||||
(1) In March 2014, the Company reserved an additional 1,000,000 shares of its common stock for future issuance under the 2011 Plan. | ||||||||||||||||
The aggregate intrinsic value of stock options exercised during the three months ended September 30, 2014 and 2013 was $1.1 million and $2.6 million, respectively, and $6.4 million and $11.3 million for stock options exercised during the nine months ended September 30, 2014 and 2013, respectively. The total fair value of stock options vested during the three months ended September 30, 2014 and 2013 was $1.4 million and $2.3 million, respectively, and $4.9 million and $7.6 million for stock options vested during the nine months ended September 30, 2014 and 2013, respectively. | ||||||||||||||||
Restricted Stock Units | ||||||||||||||||
The summary of restricted stock unit activity, which includes performance-based restricted stock units with a market condition (“PBRSUs”), is as follows (in thousands, except per share data): | ||||||||||||||||
Number of Shares | Weighted-Average Grant Date Fair Value | Aggregate Intrinsic Value | ||||||||||||||
Non-vested units - December 31, 2013 | 2,057 | $ | 12.38 | |||||||||||||
Granted | 1,416 | 14.55 | ||||||||||||||
Vested | (688 | ) | 13.45 | |||||||||||||
Forfeited | (238 | ) | 13.72 | |||||||||||||
Non-vested units - September 30, 2014 | 2,547 | 13.17 | $ | 34,976 | ||||||||||||
The total fair value of restricted stock units (“RSUs”) vested during the three months ended September 30, 2014 and 2013 was $3.0 million and $1.9 million, respectively, and $11.0 million and $4.6 million for RSUs vested during the nine months ended September 30, 2014 and 2013, respectively. | ||||||||||||||||
In October 2013, the Board of Directors approved net-share settlement for tax withholdings on RSU vesting. During the nine months ended September 30, 2014, the Company withheld issuing 244,192 shares of its common stock based on the value of the RSUs on their vesting dates as determined by the Company’s closing common stock price. Total payments for employees’ minimum tax obligations to taxing authorities were $3.8 million for the nine months ended September 30, 2014, and were recorded as a reduction to additional paid-in capital and reflected as a financing activity within the condensed consolidated statements of cash flows. The net-share settlements reduced the number of shares that would have otherwise been issued on the vesting date and increased the number of shares reserved for future issuance under the 2011 Plan. | ||||||||||||||||
Stock-Based Compensation Related to Employees and Directors | ||||||||||||||||
The fair value of RSUs granted to employees and directors is measured by reference to the fair value of the underlying shares on the date of grant. | ||||||||||||||||
PBRSUs contain both service and market conditions that affect the quantity of awards that will vest. During both the three months ended September 30, 2014 and 2013, the Company granted nil PBRSUs. During the nine months ended September 30, 2014 and 2013, the Company granted 200,000 and 175,000 PBRSUs, respectively. The Company estimates the grant date fair value of PBRSUs using the Monte Carlo simulation model. The weighted-average assumptions used to estimate the fair value of PBRSUs and the resulting fair values are as follows: | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Dividend yield | n/a | n/a | — | % | — | % | ||||||||||
Risk-free rate | n/a | n/a | 1.11 | % | 0.59 | % | ||||||||||
Expected volatility | n/a | n/a | 48 | % | 53 | % | ||||||||||
Grant date fair value | n/a | n/a | $ | 7.47 | $ | 6.39 | ||||||||||
Stock-based compensation expense related to stock options granted to employees and directors was $1.3 million and $1.8 million for the three months ended September 30, 2014 and 2013, respectively, and $4.3 million and $6.7 million for the nine months ended September 30, 2014 and 2013, respectively. Stock-based compensation expense related to RSUs granted to employees and directors was $3.0 million and $2.0 million for the three months ended September 30, 2014 and 2013, respectively, and $8.6 million and $4.8 million for the nine months ended September 30, 2014 and 2013, respectively. Stock-based compensation expense related to PBRSUs granted to employees was $0.2 million and $0.1 million for the three months ended September 30, 2014 and 2013, respectively, and $0.6 million and $0.3 million for the nine months ended September 30, 2014 and 2013, respectively. | ||||||||||||||||
As of September 30, 2014, there was $5.6 million and $31.0 million of unrecognized compensation cost related to stock options and RSUs, including PBRSUs, respectively, which is expected to be recognized over a weighted-average period of 1.6 years and 2.8 years, respectively. Future grants of equity awards will increase the amount of stock-based compensation expense to be recorded. | ||||||||||||||||
Stock-Based Compensation Related to Non-Employees | ||||||||||||||||
The Company periodically grants equity awards to non-employees in exchange for goods and services. No equity awards were granted to non-employees in exchange for goods and services during the three or nine months ended September 30, 2014 and 2013. | ||||||||||||||||
Stock-based compensation expense for non-employees is based on the fair value of the award on the measurement date, which is the earlier of the date by which the commitment for performance by the non-employee to earn the award is reached and the date on which the non-employee’s performance is complete. Each reporting period, the fair value of the unvested non-employee stock option or RSU is revalued until the award vests on the measurement date. | ||||||||||||||||
Non-employee stock-based compensation expense related to stock options was nil and $0.1 million for the three months ended September 30, 2014 and 2013, respectively, and nil and $0.2 million for the nine months ended September 30, 2014 and 2013, respectively. Non-employee stock-based compensation expense related to RSUs was nil for both the three months ended September 30, 2014 and 2013, respectively, and nil and $0.2 million for the nine months ended September 30, 2014 and 2013, respectively. |
Income_Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2014 | |
Income Tax Disclosure [Abstract] | ' |
Income Taxes | ' |
Income Taxes | |
The Company uses an estimated annual effective tax rate based upon a projection of its annual fiscal year results to measure the income tax benefit or expense recognized in each interim period. The Company’s effective tax rate, including the impact of discrete benefit items, was 37% for each of the three and nine months ended September 30, 2014 and 2013, respectively. | |
The Company’s 2010 tax year is currently under examination by the State of California Franchise Tax Board. The Company does not expect a material impact on its condensed consolidated financial statements as a result of this examination. The 2011 through 2013 tax periods remain open to examination by the Internal Revenue Service and the 2009 through 2013 tax periods remain open to examination by most state tax authorities. For the Company’s foreign jurisdictions, the 2009 through 2013 tax years remain open to examination by their respective tax authorities. |
RelatedParty_Transactions
Related-Party Transactions | 9 Months Ended |
Sep. 30, 2014 | |
Related Party Transactions [Abstract] | ' |
Related Party Transactions | ' |
Related-Party Transactions | |
During the three and nine months ended September 30, 2014, five members of the Company’s Board of Directors also served on the boards of directors of RPX clients. During the three and nine months ended September 30, 2013, four members of the Company’s Board of Directors also served on the boards of directors of RPX clients. The Company recognized subscription revenue from these clients in the amount of $2.2 million and $1.3 million for the three months ended September 30, 2014 and 2013, respectively, and $6.5 million and $3.8 million for the nine months ended September 30, 2014 and 2013, respectively. As of December 31, 2013, there was $4.4 million of receivables due from these clients. There were no receivables due from these clients on September 30, 2014. |
Segment_Reporting
Segment Reporting | 9 Months Ended | |||||||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||||||||||||
Segment Reporting | ' | |||||||||||||||||||||||||||
Segment Reporting | ||||||||||||||||||||||||||||
Operating segments are components of an enterprise about which separate financial information is available. Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis and, as a result, the Company concluded that there is only one operating and reportable segment. | ||||||||||||||||||||||||||||
The Company markets its solution to companies around the world. Revenue is generally attributed to geographic areas based on the country in which the client is domiciled. | ||||||||||||||||||||||||||||
The following table presents revenue by location and revenue generated by country as a percentage of total revenue for the applicable period, for countries representing 10% or more of revenues for the periods presented (dollars in thousands): | ||||||||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||
United States | $ | 42,751 | 65 | % | $ | 35,842 | 61 | % | $ | 120,696 | 63 | % | $ | 108,445 | 61 | % | ||||||||||||
Japan | 9,164 | 14 | 9,531 | 16 | 28,012 | 15 | 29,623 | 17 | ||||||||||||||||||||
Other | 13,492 | 21 | 13,181 | 23 | 42,880 | 22 | 39,161 | 22 | ||||||||||||||||||||
Total revenue | $ | 65,407 | 100 | % | $ | 58,554 | 100 | % | $ | 191,588 | 100 | % | $ | 177,229 | 100 | % | ||||||||||||
Long-lived assets information by location is presented below (in thousands): | ||||||||||||||||||||||||||||
September 30, | December 31, | |||||||||||||||||||||||||||
2014 | 2013 | |||||||||||||||||||||||||||
United States | $ | 4,198 | $ | 4,646 | ||||||||||||||||||||||||
Japan | 16 | 21 | ||||||||||||||||||||||||||
Total long-lived assets | $ | 4,214 | $ | 4,667 | ||||||||||||||||||||||||
Basis_of_Presentation_and_Sign1
Basis of Presentation and Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2014 | |
Accounting Policies [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
The accompanying condensed consolidated balance sheet as of September 30, 2014, the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2014 and 2013, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2014 and 2013, are unaudited. The condensed consolidated balance sheet as of December 31, 2013 was derived from the audited consolidated financial statements which are included in the Company’s Form 10-K for the fiscal year ended December 31, 2013, which was filed with the U.S. Securities and Exchange Commission (“SEC”) on March 10, 2014. The unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. | |
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and with the instructions for Form 10-Q and Regulation S-X for interim financial statements. Accordingly, they do not include all of the information and notes required for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring items, necessary to state fairly the results of the interim periods have been included in the accompanying financial statements. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for any subsequent interim period or for the year ending December 31, 2014. | |
There have been no material changes to the Company’s significant accounting policies during the three and nine months ended September 30, 2014, as compared to the significant accounting policies presented under the heading “Basis of Presentation and Significant Accounting Policies” in Note 2 of the Notes to Consolidated Financial Statements in Part II, Item 8 of the Company’s Annual Report on Form 10-K filed with the SEC on March 10, 2014. | |
Recently Issued Accounting Standards | ' |
Recently Issued Accounting Standards | |
In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern ("ASU 2014-15") provides new guidance related to management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards and to provide related footnote disclosures. This new guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter; early adoption is permitted. The requirements of ASU 2014-15 are not expected to have a significant impact on the condensed consolidated financial statements. | |
In June 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (“ASU 2014-12”), which amends Compensation - Stock Compensation (Topic 718) in the Accounting Standards Codification (“ASC”). ASU 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Compensation - Stock Compensation (Topic 718) as it relates to awards with performance conditions that affect vesting to account for such awards. The amendments in ASU 2014-12 will be effective for annual and interim periods beginning after December 15, 2015 and early adoption is permitted. The adoption of ASU 2014-12 is not expected to have a material impact on the Company’s consolidated financial statements. | |
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which will supersede most existing revenue recognition guidance in U.S. generally accepted accounting principles (“U.S. GAAP”) once it becomes effective. ASU 2014-09 requires an entity to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 will be effective for annual and interim periods beginning after December 15, 2016 and early adoption is not permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-12 on its consolidated financial statements. | |
In April 2014, the FASB issued ASU 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360) (“ASU 2014-08”), which amends the requirements for reporting discontinued operations and enhances disclosure requirements. The amendments in ASU 2014-08 will be effective for all disposals (or classifications as held for sale) of components of an entity beginning on or after December 15, 2014 and early adoption is permitted. The adoption of ASU 2014-08 is not expected to have a material impact on the Company’s consolidated financial statements. |
Net_Income_Available_to_Common1
Net Income Available to Common Stockholders (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Basic and Diluted Net Income Per Share Available To Common Stockholders | ' | |||||||||||||||
The following table presents the calculation of basic and diluted net income per share available to common stockholders (in thousands, except per share data): | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Net income available to common stockholders: | ||||||||||||||||
Numerator: | ||||||||||||||||
Net income | $ | 10,833 | $ | 8,397 | $ | 30,092 | $ | 33,789 | ||||||||
Allocation of net income to participating stockholders | — | (2 | ) | — | (22 | ) | ||||||||||
Net income available to common stockholders | $ | 10,833 | $ | 8,395 | $ | 30,092 | $ | 33,767 | ||||||||
Denominator: | ||||||||||||||||
Basic shares: | ||||||||||||||||
Weighted-average shares used in computing basic net income available to common stockholders | 53,773 | 52,267 | 53,263 | 51,751 | ||||||||||||
Diluted shares: | ||||||||||||||||
Weighted-average shares used in computing basic net income available to common stockholders | 53,773 | 52,267 | 53,263 | 51,751 | ||||||||||||
Dilutive effect of stock options and restricted stock units using the treasury-stock method | 1,256 | 1,788 | 1,479 | 1,664 | ||||||||||||
Weighted-average shares used in computing diluted net income available to common stockholders | 55,029 | 54,055 | 54,742 | 53,415 | ||||||||||||
Net income per common share available to common stockholders: | ||||||||||||||||
Basic | $ | 0.2 | $ | 0.16 | $ | 0.56 | $ | 0.65 | ||||||||
Diluted | $ | 0.2 | $ | 0.16 | $ | 0.55 | $ | 0.63 | ||||||||
Anti-Dilutive Securities Not Included In Diluted Shares Outstanding Calculation | ' | |||||||||||||||
The following securities were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive (in thousands): | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Weighted-average: | ||||||||||||||||
Stock options outstanding | 763 | 1,059 | 749 | 1,360 | ||||||||||||
Restricted stock units outstanding | 245 | 143 | 30 | 255 | ||||||||||||
Shares of common stock subject to repurchase | — | 13 | — | 34 | ||||||||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 9 Months Ended | |||||||||||
Sep. 30, 2014 | ||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||
Finance Assets Measured At Fair Value On A Recurring Basis | ' | |||||||||||
The following tables present the Company’s financial assets measured at fair value on a recurring basis (in thousands): | ||||||||||||
September 30, 2014 | ||||||||||||
Fair Value | Level 1 | Level 2 | ||||||||||
Cash equivalents: | ||||||||||||
Commercial paper | $ | 24,179 | $ | — | $ | 24,179 | ||||||
Money market funds | 1,026 | 1,026 | — | |||||||||
Municipal bonds | 4,057 | — | 4,057 | |||||||||
$ | 29,262 | $ | 1,026 | $ | 28,236 | |||||||
Short-term investments: | ||||||||||||
Municipal bonds | $ | 127,562 | $ | — | $ | 127,562 | ||||||
Corporate bonds | 56,070 | — | 56,070 | |||||||||
Commercial paper | 2,497 | — | 2,497 | |||||||||
U.S. government and agency securities | 33,675 | — | 33,675 | |||||||||
$ | 219,804 | $ | — | $ | 219,804 | |||||||
December 31, 2013 | ||||||||||||
Fair Value | Level 1 | Level 2 | ||||||||||
Cash equivalents: | ||||||||||||
Commercial paper | $ | 34,498 | $ | — | $ | 34,498 | ||||||
U.S. government and agency securities | 3,801 | — | 3,801 | |||||||||
Money market funds | 37 | 37 | — | |||||||||
$ | 38,336 | $ | 37 | $ | 38,299 | |||||||
Short-term investments: | ||||||||||||
Municipal bonds | $ | 146,100 | $ | — | $ | 146,100 | ||||||
Commercial paper | 31,597 | — | 31,597 | |||||||||
Corporate bonds | 7,875 | — | 7,875 | |||||||||
U.S. government and agency securities | 4,995 | — | 4,995 | |||||||||
$ | 190,567 | $ | — | $ | 190,567 | |||||||
Shortterm_Investments_Tables
Short-term Investments (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Short-term Investments [Abstract] | ' | |||||||||||||||
Summary Of Investments In Available-For-Sale Securities | ' | |||||||||||||||
The following tables present the Company’s investments in available-for-sale securities (in thousands): | ||||||||||||||||
September 30, 2014 | ||||||||||||||||
Unrealized | ||||||||||||||||
Amortized Cost | Gains | Losses | Estimated Fair Value | |||||||||||||
Municipal bonds | $ | 127,516 | $ | 52 | $ | (6 | ) | $ | 127,562 | |||||||
Corporate bonds | 56,150 | 2 | (82 | ) | 56,070 | |||||||||||
Commercial paper | 2,497 | — | — | 2,497 | ||||||||||||
U.S. government and agency securities | 33,693 | 4 | (22 | ) | 33,675 | |||||||||||
$ | 219,856 | $ | 58 | $ | (110 | ) | $ | 219,804 | ||||||||
December 31, 2013 | ||||||||||||||||
Unrealized | ||||||||||||||||
Amortized Cost | Gains | Losses | Estimated Fair Value | |||||||||||||
Municipal bonds | $ | 146,047 | $ | 56 | $ | (3 | ) | $ | 146,100 | |||||||
Commercial paper | 31,597 | — | — | 31,597 | ||||||||||||
Corporate bonds | 7,873 | 2 | — | 7,875 | ||||||||||||
U.S. government and agency securities | 5,002 | — | (7 | ) | 4,995 | |||||||||||
$ | 190,519 | $ | 58 | $ | (10 | ) | $ | 190,567 | ||||||||
Patent_Assets_Net_Tables
Patent Assets, Net (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Patent Assets, Net [Abstract] | ' | |||||||||||||||
Patent Assets, Net | ' | |||||||||||||||
Patent assets, net, consisted of the following (in thousands): | ||||||||||||||||
December 31, | Additions | Sales | September 30, | |||||||||||||
2013 | 2014 | |||||||||||||||
Patent assets | $ | 529,526 | $ | 115,658 | $ | (705 | ) | $ | 644,479 | |||||||
Accumulated amortization | (309,572 | ) | (87,181 | ) | 325 | (396,428 | ) | |||||||||
Patent assets, net | $ | 219,954 | $ | 248,051 | ||||||||||||
Expected Future Annual Amortization Of Patent Assets | ' | |||||||||||||||
As of September 30, 2014, the Company expects amortization expense in future periods to be as follows (in thousands): | ||||||||||||||||
2014 (remainder) | $ | 31,371 | ||||||||||||||
2015 | 103,961 | |||||||||||||||
2016 | 73,434 | |||||||||||||||
2017 | 31,714 | |||||||||||||||
2018 | 6,788 | |||||||||||||||
Thereafter | 783 | |||||||||||||||
Total estimated future amortization expense | $ | 248,051 | ||||||||||||||
Property_and_Equipment_Net_Tab
Property and Equipment, Net (Tables) | 9 Months Ended | |||||||
Sep. 30, 2014 | ||||||||
Property, Plant and Equipment, Net, by Type [Abstract] | ' | |||||||
Property And Equipment, Net | ' | |||||||
Property and equipment, net, consisted of the following (in thousands): | ||||||||
September 30, | December 31, | |||||||
2014 | 2013 | |||||||
Internal-use software | $ | 4,931 | $ | 4,198 | ||||
Leasehold improvements | 1,799 | 1,700 | ||||||
Computer, equipment and software | 1,207 | 1,096 | ||||||
Furniture and fixtures | 818 | 813 | ||||||
Construction-in-progress | 181 | 119 | ||||||
Total property and equipment, gross | 8,936 | 7,926 | ||||||
Less: Accumulated depreciation and amortization | (4,722 | ) | (3,259 | ) | ||||
Total property and equipment, net | $ | 4,214 | $ | 4,667 | ||||
Goodwill_Goodwill_Tables
Goodwill (Goodwill Tables) | 9 Months Ended | |||
Sep. 30, 2014 | ||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||
Schedule of Goodwill | ' | |||
The changes in the carrying amounts of goodwill were as follows (in thousands): | ||||
Balance as of December 31, 2013 | $ | 16,460 | ||
Goodwill from business acquisition | 3,518 | |||
Balance as of September 30, 2014 | $ | 19,978 | ||
Intangible_Assets_Net_Tables
Intangible Assets, Net (Tables) | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ' | |||||||||||||||||||||||
Intangible Assets, Net | ' | |||||||||||||||||||||||
Intangible assets, net, consisted of the following (in thousands): | ||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||||||||||||
Carrying Amount | Accumulated Amortization | Net Carrying Amount | Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||||||
Covenant not to compete | $ | 1,920 | $ | (199 | ) | $ | 1,721 | $ | 480 | $ | (469 | ) | $ | 11 | ||||||||||
Proprietary data and models | 2,100 | (975 | ) | 1,125 | 1,500 | (637 | ) | 863 | ||||||||||||||||
Customer relationships | 1,050 | (326 | ) | 724 | 250 | (215 | ) | 35 | ||||||||||||||||
Trademarks | 1,890 | (1,503 | ) | 387 | 1,890 | (1,184 | ) | 706 | ||||||||||||||||
Developed technology | 728 | (723 | ) | 5 | 728 | (625 | ) | 103 | ||||||||||||||||
$ | 7,688 | $ | (3,726 | ) | $ | 3,962 | $ | 4,848 | $ | (3,130 | ) | $ | 1,718 | |||||||||||
Expected Future Annual Amortization Of Intangible Assets | ' | |||||||||||||||||||||||
As of September 30, 2014, the Company expects amortization expense in future periods to be as follows (in thousands): | ||||||||||||||||||||||||
2014 (remainder) | $ | 31,371 | ||||||||||||||||||||||
2015 | 103,961 | |||||||||||||||||||||||
2016 | 73,434 | |||||||||||||||||||||||
2017 | 31,714 | |||||||||||||||||||||||
2018 | 6,788 | |||||||||||||||||||||||
Thereafter | 783 | |||||||||||||||||||||||
Total estimated future amortization expense | $ | 248,051 | ||||||||||||||||||||||
Intangible Assets Net | ' | |||||||||||||||||||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ' | |||||||||||||||||||||||
Expected Future Annual Amortization Of Intangible Assets | ' | |||||||||||||||||||||||
As of September 30, 2014, the Company expects amortization expense in future periods to be as follows (in thousands): | ||||||||||||||||||||||||
2014 (remainder) | $ | 437 | ||||||||||||||||||||||
2015 | 1,725 | |||||||||||||||||||||||
2016 | 1,288 | |||||||||||||||||||||||
2017 | 512 | |||||||||||||||||||||||
Total estimated future amortization expense | $ | 3,962 | ||||||||||||||||||||||
Accrued_and_Other_Current_Liab1
Accrued and Other Current Liabilities (Tables) | 9 Months Ended | |||||||
Sep. 30, 2014 | ||||||||
Payables and Accruals [Abstract] | ' | |||||||
Accrued And Other Current Liabilities | ' | |||||||
Accrued and other current liabilities consisted of the following (in thousands): | ||||||||
September 30, | December 31, | |||||||
2014 | 2013 | |||||||
Accrued payroll-related expenses | $ | 7,579 | $ | 6,791 | ||||
Accrued expenses | 3,414 | 1,993 | ||||||
Total accrued liabilities | $ | 10,993 | $ | 8,784 | ||||
Other current liabilities | $ | 691 | $ | 1,075 | ||||
Consideration payable for business acquisition | 425 | — | ||||||
Patent and other assets purchased but not paid | 12,200 | 563 | ||||||
Total other current liabilities | $ | 13,316 | $ | 1,638 | ||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Stockholders Equity and Share-based Compensation [Abstract] | ' | |||||||||||||||
Activity Under Equity Settled Award Plans And Related Information | ' | |||||||||||||||
A summary of the Company’s activity under its equity-settled award plans and related information is as follows (in thousands, except per share data): | ||||||||||||||||
Options Outstanding | ||||||||||||||||
Shares Available for Grant | Number of Shares | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Life in Years | Aggregate Intrinsic Value | ||||||||||||
Balance - December 31, 2013 | 2,451 | 4,089 | $ | 9.91 | ||||||||||||
Shares authorized(1) | 1,000 | — | — | |||||||||||||
Options exercised | — | (561 | ) | 5.11 | ||||||||||||
Options forfeited/canceled | 173 | (173 | ) | 17.51 | ||||||||||||
Restricted stock units granted | (1,416 | ) | — | — | ||||||||||||
Restricted stock units forfeited | 238 | — | — | |||||||||||||
Restricted stock units withheld related to net-share settlement of restricted stock units | 244 | — | — | |||||||||||||
Balance - September 30, 2014 | 2,690 | 3,355 | 10.32 | 6.4 | $ | 14,912 | ||||||||||
Vested and exercisable - September 30, 2014 | 2,360 | 10.47 | 6.3 | 10,706 | ||||||||||||
Vested and expected to vest - September 30, 2014 | 3,237 | 10.34 | 6.4 | 14,397 | ||||||||||||
(1) In March 2014, the Company reserved an additional 1,000,000 shares of its common stock for future issuance under the 2011 Plan. | ||||||||||||||||
Restricted Stock Unit Activity | ' | |||||||||||||||
The summary of restricted stock unit activity, which includes performance-based restricted stock units with a market condition (“PBRSUs”), is as follows (in thousands, except per share data): | ||||||||||||||||
Number of Shares | Weighted-Average Grant Date Fair Value | Aggregate Intrinsic Value | ||||||||||||||
Non-vested units - December 31, 2013 | 2,057 | $ | 12.38 | |||||||||||||
Granted | 1,416 | 14.55 | ||||||||||||||
Vested | (688 | ) | 13.45 | |||||||||||||
Forfeited | (238 | ) | 13.72 | |||||||||||||
Non-vested units - September 30, 2014 | 2,547 | 13.17 | $ | 34,976 | ||||||||||||
Weighted-Average Assumptions Used To Estimate The Fair Value Of PBRSUs | ' | |||||||||||||||
The weighted-average assumptions used to estimate the fair value of PBRSUs and the resulting fair values are as follows: | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Dividend yield | n/a | n/a | — | % | — | % | ||||||||||
Risk-free rate | n/a | n/a | 1.11 | % | 0.59 | % | ||||||||||
Expected volatility | n/a | n/a | 48 | % | 53 | % | ||||||||||
Grant date fair value | n/a | n/a | $ | 7.47 | $ | 6.39 | ||||||||||
Segment_Reporting_Tables
Segment Reporting (Tables) | 9 Months Ended | |||||||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||||||||||||
Revenue By Location | ' | |||||||||||||||||||||||||||
The following table presents revenue by location and revenue generated by country as a percentage of total revenue for the applicable period, for countries representing 10% or more of revenues for the periods presented (dollars in thousands): | ||||||||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||
United States | $ | 42,751 | 65 | % | $ | 35,842 | 61 | % | $ | 120,696 | 63 | % | $ | 108,445 | 61 | % | ||||||||||||
Japan | 9,164 | 14 | 9,531 | 16 | 28,012 | 15 | 29,623 | 17 | ||||||||||||||||||||
Other | 13,492 | 21 | 13,181 | 23 | 42,880 | 22 | 39,161 | 22 | ||||||||||||||||||||
Total revenue | $ | 65,407 | 100 | % | $ | 58,554 | 100 | % | $ | 191,588 | 100 | % | $ | 177,229 | 100 | % | ||||||||||||
Long-Lived Assets Information By Location | ' | |||||||||||||||||||||||||||
Long-lived assets information by location is presented below (in thousands): | ||||||||||||||||||||||||||||
September 30, | December 31, | |||||||||||||||||||||||||||
2014 | 2013 | |||||||||||||||||||||||||||
United States | $ | 4,198 | $ | 4,646 | ||||||||||||||||||||||||
Japan | 16 | 21 | ||||||||||||||||||||||||||
Total long-lived assets | $ | 4,214 | $ | 4,667 | ||||||||||||||||||||||||
Net_Income_Available_to_Common2
Net Income Available to Common Stockholders (Detail) - Basic and Diluted Net Income Per Share Available To Common Stockholders (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Numerator: | ' | ' | ' | ' |
Net income | $10,833 | $8,397 | $30,092 | $33,789 |
Allocation of net income to participating stockholders | 0 | -2 | 0 | -22 |
Net income available to common stockholders | $10,833 | $8,395 | $30,092 | $33,767 |
Basic shares: | ' | ' | ' | ' |
Weighted-average shares used in computing basic net income available to common stockholders | 53,773 | 52,267 | 53,263 | 51,751 |
Diluted shares: | ' | ' | ' | ' |
Dilutive effect of stock options and restricted stock units using the treasury-stock method | 1,256 | 1,788 | 1,479 | 1,664 |
Weighted-average shares used in computing diluted net income available to common stockholders | 55,029 | 54,055 | 54,742 | 53,415 |
Net income per common share available to common stockholders: | ' | ' | ' | ' |
Basic (dollars per common share) | $0.20 | $0.16 | $0.56 | $0.65 |
Diluted (dollars per common share) | $0.20 | $0.16 | $0.55 | $0.63 |
Net_Income_Available_to_Common3
Net Income Available to Common Stockholders (Detail) - Anti-Dilutive Securities Not Included In Diluted Shares Outstanding Calculation | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Stock options outstanding | ' | ' | ' | ' |
Weighted-average: | ' | ' | ' | ' |
Weighted-average anti-dilutive securities | 763 | 1,059 | 749 | 1,360 |
Restricted stock units outstanding | ' | ' | ' | ' |
Weighted-average: | ' | ' | ' | ' |
Weighted-average anti-dilutive securities | 245 | 143 | 30 | 255 |
Shares of common stock subject to repurchase | ' | ' | ' | ' |
Weighted-average: | ' | ' | ' | ' |
Weighted-average anti-dilutive securities | 0 | 13 | 0 | 34 |
Fair_Value_Measurements_Detail
Fair Value Measurements (Detail) - Financial Assets Measured At Fair Value On A Recurring Basis (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Cash equivalents | ' | ' |
Cash equivalents | $29,262 | $38,336 |
Short-term investments | ' | ' |
Short-term investments | 219,804 | 190,567 |
Municipal bonds | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 127,562 | 146,100 |
Corporate bonds | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 56,070 | 7,875 |
Commercial paper | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 2,497 | 31,597 |
U.S. government and agency securities | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 33,675 | 4,995 |
Commercial paper | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 24,179 | 34,498 |
Money market funds | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 1,026 | 37 |
Municipal bonds | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 4,057 | ' |
U.S. government and agency securities | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | ' | 3,801 |
Fair Value, Inputs, Level 1 | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 1,026 | 37 |
Short-term investments | ' | ' |
Short-term investments | 0 | 0 |
Fair Value, Inputs, Level 1 | Municipal bonds | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 0 | 0 |
Fair Value, Inputs, Level 1 | Corporate bonds | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 0 | 0 |
Fair Value, Inputs, Level 1 | Commercial paper | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 0 | 0 |
Fair Value, Inputs, Level 1 | U.S. government and agency securities | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 0 | 0 |
Fair Value, Inputs, Level 1 | Commercial paper | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 0 | 0 |
Fair Value, Inputs, Level 1 | Money market funds | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 1,026 | 37 |
Fair Value, Inputs, Level 1 | Municipal bonds | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 0 | ' |
Fair Value, Inputs, Level 1 | U.S. government and agency securities | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | ' | 0 |
Fair Value, Inputs, Level 2 | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 28,236 | 38,299 |
Short-term investments | ' | ' |
Short-term investments | 219,804 | 190,567 |
Fair Value, Inputs, Level 2 | Municipal bonds | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 127,562 | 146,100 |
Fair Value, Inputs, Level 2 | Corporate bonds | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 56,070 | 7,875 |
Fair Value, Inputs, Level 2 | Commercial paper | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 2,497 | 31,597 |
Fair Value, Inputs, Level 2 | U.S. government and agency securities | ' | ' |
Short-term investments | ' | ' |
Short-term investments | 33,675 | 4,995 |
Fair Value, Inputs, Level 2 | Commercial paper | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 24,179 | 34,498 |
Fair Value, Inputs, Level 2 | Money market funds | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 0 | 0 |
Fair Value, Inputs, Level 2 | Municipal bonds | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | 4,057 | ' |
Fair Value, Inputs, Level 2 | U.S. government and agency securities | ' | ' |
Cash equivalents | ' | ' |
Cash equivalents | ' | $3,801 |
Shortterm_Investments_Detail_S
Short-term Investments (Detail) - Summary Of Investments In Available-For-Sale Securities (USD $) | 9 Months Ended | 12 Months Ended |
In Thousands, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 |
Investment Holdings [Line Items] | ' | ' |
Amortized Cost | $219,856 | $190,519 |
Unrealized Gains | 58 | 58 |
Unrealized Losses | -110 | -10 |
Estimated Fair Value | 219,804 | 190,567 |
Municipal bonds | ' | ' |
Investment Holdings [Line Items] | ' | ' |
Amortized Cost | 127,516 | 146,047 |
Unrealized Gains | 52 | 56 |
Unrealized Losses | -6 | -3 |
Estimated Fair Value | 127,562 | 146,100 |
Corporate bonds | ' | ' |
Investment Holdings [Line Items] | ' | ' |
Amortized Cost | 56,150 | 7,873 |
Unrealized Gains | 2 | 2 |
Unrealized Losses | -82 | 0 |
Estimated Fair Value | 56,070 | 7,875 |
Commercial paper | ' | ' |
Investment Holdings [Line Items] | ' | ' |
Amortized Cost | 2,497 | 31,597 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Estimated Fair Value | 2,497 | 31,597 |
U.S. government and agency securities | ' | ' |
Investment Holdings [Line Items] | ' | ' |
Amortized Cost | 33,693 | 5,002 |
Unrealized Gains | 4 | 0 |
Unrealized Losses | -22 | -7 |
Estimated Fair Value | $33,675 | $4,995 |
Patent_Assets_Net_Detail
Patent Assets, Net (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' | ' |
Accumulated amortization - Additions | $500 | $300 | $1,100 | $1,100 |
Patents | ' | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' | ' |
Accumulated amortization - Additions | $29,500 | $28,200 | $87,181 | $74,500 |
Minimum | Patents | ' | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' | ' |
Patent assets, useful life | ' | ' | '24 months | ' |
Maximum | Patents | ' | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' | ' |
Patent assets, useful life | ' | ' | '60 months | ' |
Weighted Average | Patents | ' | ' | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' | ' | ' |
Patent assets, useful life | '46 months | ' | ' | ' |
Patent_Assets_Net_Detail_Paten
Patent Assets, Net (Detail) - Patent Assets, Net (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Finite-lived Intangible Assets [Roll Forward] | ' | ' | ' | ' | ' |
Patent assets, beginning balance | ' | ' | $4,848 | ' | ' |
Patent assets - Additions | ' | ' | 103,958 | 82,751 | ' |
Patent assets, ending balance | 7,688 | ' | 7,688 | ' | ' |
Accumulated amortization, beginning balance | ' | ' | -3,130 | ' | ' |
Accumulated amortization - Additions | -500 | -300 | -1,100 | -1,100 | ' |
Accumulated amortization, ending balance | -3,726 | ' | -3,726 | ' | ' |
Patent assets, net | 248,051 | ' | 248,051 | ' | 219,954 |
Patents | ' | ' | ' | ' | ' |
Finite-lived Intangible Assets [Roll Forward] | ' | ' | ' | ' | ' |
Patent assets, beginning balance | ' | ' | 529,526 | ' | ' |
Patent assets - Additions | ' | ' | 115,658 | ' | ' |
Patent assets - Sales | ' | ' | -705 | ' | ' |
Patent assets, ending balance | 644,479 | ' | 644,479 | ' | ' |
Accumulated amortization, beginning balance | ' | ' | -309,572 | ' | ' |
Accumulated amortization - Additions | -29,500 | -28,200 | -87,181 | -74,500 | ' |
Accumulated amortization - Sales | ' | ' | 325 | ' | ' |
Accumulated amortization, ending balance | -396,428 | ' | -396,428 | ' | ' |
Patent assets, net | $248,051 | ' | $248,051 | ' | $219,954 |
Patent_Assets_Net_Detail_Expec
Patent Assets, Net (Detail) - Expected Future Annual Amortization Expense Of Patent Assets (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Finite-Lived Intangible Assets [Line Items] | ' | ' |
2014 (remainder) | $437 | ' |
2015 | 1,725 | ' |
2016 | 1,288 | ' |
2017 | 512 | ' |
Patent assets, net | 248,051 | 219,954 |
Patents | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
2014 (remainder) | 31,371 | ' |
2015 | 103,961 | ' |
2016 | 73,434 | ' |
2017 | 31,714 | ' |
2018 | 6,788 | ' |
Thereafter | 783 | ' |
Patent assets, net | $248,051 | $219,954 |
Property_and_Equipment_Net_Det
Property and Equipment, Net (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Property, Plant and Equipment [Line Items] | ' | ' | ' | ' |
Depreciation and amortization expense | ' | ' | $89,700,000 | $76,767,000 |
Internal-use software | ' | ' | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' | ' | ' |
Stock-based compensation capitalized as part of internal-use software | 0 | 0 | 100,000 | 0 |
Property and equipment, types | ' | ' | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' | ' | ' |
Depreciation and amortization expense | $500,000 | $400,000 | $1,500,000 | $1,200,000 |
Property_and_Equipment_Net_Det1
Property and Equipment, Net (Detail) - Property And Equipment, Net (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Property, Plant and Equipment [Line Items] | ' | ' |
Total property and equipment, gross | $8,936 | $7,926 |
Less: Accumulated depreciation and amortization | -4,722 | -3,259 |
Total property and equipment, net | 4,214 | 4,667 |
Internal-use software | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Internal-use software | 4,931 | 4,198 |
Leasehold improvements | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Leasehold improvements | 1,799 | 1,700 |
Computer, equipment and software | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Computer, equipment and software | 1,207 | 1,096 |
Furniture and fixtures | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Furniture and fixtures | 818 | 813 |
Construction-in-progress | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Construction-in-progress | $181 | $119 |
Business_Combinations_Details
Business Combinations (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | Jun. 19, 2014 | Sep. 30, 2014 | Jun. 19, 2014 |
DCML Services Corporation | DCML Services Corporation | DCML Services Corporation | |||
Business Acquisition [Line Items] | ' | ' | ' | ' | ' |
Business combination, consideration transferred | ' | ' | $6,200,000 | ' | ' |
Payments to acquire businesses | ' | ' | 3,000,000 | 2,600,000 | ' |
Business acquisition, equity interest issued or issuable, number of shares | ' | ' | 182,408 | ' | ' |
Business combination, consideration transferred, equity interests issued and issuable | ' | ' | 3,200,000 | ' | ' |
Business combination, recognized identifiable assets acquired, intangible assets | ' | ' | ' | ' | 3,300,000 |
Business combination, recognized identifiable liabilities assumed, deferred tax liabilities | ' | ' | ' | ' | 1,100,000 |
Business combination, recognized identifiable assets acquired, tangible assets | ' | ' | ' | ' | 500,000 |
Goodwill | 19,978,000 | 16,460,000 | ' | ' | 3,500,000 |
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | ' | ' | '3 years | ' | ' |
Business acquisition, transaction costs | ' | ' | ' | $100,000 | ' |
Goodwill_Details
Goodwill (Details) (USD $) | 9 Months Ended |
In Thousands, unless otherwise specified | Sep. 30, 2014 |
Goodwill [Roll Forward] | ' |
Balance as of December 31, 2013 | $16,460 |
Goodwill from business acquisition | 3,518 |
Balance as of September 30, 2014 | $19,978 |
Intangible_Assets_Net_Detail
Intangible Assets, Net (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' | ' | ' | ' |
Amortization of intangible assets | $0.50 | $0.30 | $1.10 | $1.10 |
Intangible_Assets_Net_Detail_I
Intangible Assets, Net (Detail) - Intangible Assets, Net (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Carrying amount | $7,688 | $4,848 |
Accumulated amortization | -3,726 | -3,130 |
Total estimated future amortization expense | 3,962 | 1,718 |
Covenant not to compete | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Carrying amount | 1,920 | 480 |
Accumulated amortization | -199 | -469 |
Total estimated future amortization expense | 1,721 | 11 |
Proprietary data and models | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Carrying amount | 2,100 | 1,500 |
Accumulated amortization | -975 | -637 |
Total estimated future amortization expense | 1,125 | 863 |
Customer relationships | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Carrying amount | 1,050 | 250 |
Accumulated amortization | -326 | -215 |
Total estimated future amortization expense | 724 | 35 |
Trademarks | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Carrying amount | 1,890 | 1,890 |
Accumulated amortization | -1,503 | -1,184 |
Total estimated future amortization expense | 387 | 706 |
Developed technology | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Carrying amount | 728 | 728 |
Accumulated amortization | -723 | -625 |
Total estimated future amortization expense | $5 | $103 |
Intangible_Assets_Net_Detail_E
Intangible Assets, Net (Detail) - Estimated Future Amortization Expenses For Intangible Assets (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' | ' |
2014 (remainder) | $437 | ' |
2015 | 1,725 | ' |
2016 | 1,288 | ' |
2017 | 512 | ' |
Total estimated future amortization expense | $3,962 | $1,718 |
Accrued_and_Other_Current_Liab2
Accrued and Other Current Liabilities (Detail) - Accrued And Other Current Liabilities (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' | ' |
Accrued liabilities | $10,993 | $8,784 |
Other current liabilities | 13,316 | 1,638 |
Consideration payable for business acquisition | 425 | 0 |
Accrued payroll-related expenses | ' | ' |
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' | ' |
Accrued liabilities | 7,579 | 6,791 |
Accrued expenses | ' | ' |
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' | ' |
Accrued liabilities | 3,414 | 1,993 |
Other current liabilities | ' | ' |
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' | ' |
Other current liabilities | 691 | 1,075 |
Patent and other assets purchased but not paid | ' | ' |
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' | ' |
Other current liabilities | $12,200 | $563 |
Commitments_and_Contingencies_
Commitments and Contingencies (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
insurance_policy | insurance_policy | |||
Commitments and Contingencies Disclosure [Abstract] | ' | ' | ' | ' |
Rent expense related to non-cancelable operating leases net of sublease income | $900,000 | $1,100,000 | $2,700,000 | $2,500,000 |
Sublease income | 200,000 | 0 | 400,000 | 0 |
Number of active insurance policies | 38 | ' | 38 | ' |
Reserves for known and incurred but not reported claims | $1,600,000 | ' | $1,600,000 | ' |
StockBased_Compensation_Detail
Stock-Based Compensation (Detail) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | |
Additional shares of common stock reserved for issuance under the 2011 Plan (in shares) | ' | ' | 1,000,000 | [1] | ' |
Aggregate intrinsic value of stock options exercised | $1,100,000 | $2,600,000 | $6,400,000 | $11,300,000 | |
Total fair value of stock options vested | 1,400,000 | 2,300,000 | 4,900,000 | 7,600,000 | |
Total fair value of RSUs vested | 3,000,000 | 1,900,000 | 11,000,000 | 4,600,000 | |
Shares withheld for tax withholdings (in shares) | ' | ' | 244,192 | ' | |
Total payments for the employees’ minimum tax obligations to taxing authorities | ' | ' | 3,848,000 | 0 | |
PBRSUs granted (in shares) | 0 | 0 | 200,000 | 175,000 | |
Stock options | ' | ' | ' | ' | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | |
Stock-based compensation expense | 1,300,000 | 1,800,000 | 4,300,000 | 6,700,000 | |
Unrecognized compensation cost related to unvested equity awards | 5,600,000 | ' | 5,600,000 | ' | |
Weighted-average service period of unrecognized compensation cost related to unvested equity awards | ' | ' | '1 year 7 months 0 days | ' | |
Non-employee stock-based compensation expense | 0 | 100,000 | 0 | 200,000 | |
Restricted stock | ' | ' | ' | ' | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | |
Stock-based compensation expense | 3,000,000 | 2,000,000 | 8,600,000 | 4,800,000 | |
Unrecognized compensation cost related to unvested equity awards | 31,000,000 | ' | 31,000,000 | ' | |
Weighted-average service period of unrecognized compensation cost related to unvested equity awards | ' | ' | '2 years 10 months 0 days | ' | |
Non-employee stock-based compensation expense | 0 | ' | 0 | 200,000 | |
Performance-based restricted stock units with a market condition | ' | ' | ' | ' | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | |
Stock-based compensation expense | $200,000 | $100,000 | $600,000 | $300,000 | |
2011 Plan | ' | ' | ' | ' | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | |
Additional shares of common stock reserved for issuance under the 2011 Plan (in shares) | ' | ' | 1,000,000 | ' | |
[1] | In March 2014, the Company reserved an additional 1,000,000 shares of its common stock for future issuance under the 2011 Plan. |
StockBased_Compensation_Detail1
Stock-Based Compensation (Detail) - Activity Under Equity Award Plans And Related Information (USD $) | 9 Months Ended | |
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | |
Shares Available for Grant - Outstanding, beginning balance (in shares) | 2,451,000 | |
Number of Shares - Outstanding, beginning balance (in shares) | 4,089,000 | |
Weighted-Average Exercise Price - Outstanding, beginning balance (in dollars per share) | $9.91 | |
Shares Available for Grant - Shares authorized (in shares) | 1,000,000 | [1] |
Number of Shares - Options exercised (in shares) | -561,000 | |
Weighted Average Exercise Price - Options exercised (in dollars per share) | $5.11 | |
Shares Available for Grant - Options forfeited/canceled | 173,000 | |
Number of Shares - Options forfeited/canceled (in shares) | -173,000 | |
Weighted-Average Exercise Price - Options forfeited/canceled (in dollars per share) | $17.51 | |
Share Available for Grant - Restricted stock units granted (in shares) | -1,416,000 | |
Shares Available for Grant - Restricted stock units forfeited (in shares) | 238,000 | |
Shares Available for Grant - Restricted stock units withheld related to net-share settlement of restricted stock units (in shares) | 244,000 | |
Shares Available for Grant - Outstanding, ending balance (in shares) | 2,690,000 | |
Number of Shares - Outstanding, ending balance (in shares) | 3,355,000 | |
Weighted-Average Exercise Price - Outstanding, ending balance (in dollars per share) | $10.32 | |
Outstanding (weighted-average contractual life) | '6 years 4 months 24 days | |
Outstanding (intrinsic value) | $14,912 | |
Vested and exercisable | ' | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | |
Vested and exercisable (shares) | 2,360,000 | |
Vested and exercisable (in dollars per share) | $10.47 | |
Vested and exercisable (weighted-average contractual life) | '6 years 3 months 18 days | |
Vested and exercisable (intrinsic value) | 10,706 | |
Vested and expected to vest | ' | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | |
Vested and expected to vest (shares) | 3,237,000 | |
Vested and expected to vest (in dollars per share) | $10.34 | |
Vested and expected to vest (weighted-average contractual life) | '6 years 4 months 24 days | |
Vested and expected to vest (intrinsic value) | $14,397 | |
[1] | In March 2014, the Company reserved an additional 1,000,000 shares of its common stock for future issuance under the 2011 Plan. |
StockBased_Compensation_Detail2
Stock-Based Compensation (Detail) - Restricted Stock Unit Activity (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 |
In Thousands, except Share data, unless otherwise specified | Restricted stock units granted | Restricted stock units vested | Restricted stock units forfeited | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' | ' | ' |
Non-vested units, beginning balance (in shares) | 2,547,000 | 2,057,000 | ' | ' | ' |
Non-vested units, beginning balance (in dollars per share) | $13.17 | $12.38 | ' | ' | ' |
Granted (in shares) | ' | ' | 1,416,000 | ' | ' |
Granted (in dollars per share) | ' | ' | $14.55 | ' | ' |
Vested (in shares) | ' | ' | ' | -688,000 | ' |
Vested (in dollars per share) | ' | ' | ' | $13.45 | ' |
Forfeited (in shares) | ' | ' | ' | ' | -238,000 |
Forfeited (in dollars per share) | ' | ' | ' | ' | $13.72 |
Non-vested units, ending balance (in shares) | 2,547,000 | 2,057,000 | ' | ' | ' |
Non-vested units, ending balance (in dollars per share) | $13.17 | $12.38 | ' | ' | ' |
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, intrinsic value | $34,976 | ' | ' | ' | ' |
StockBased_Compensation_Detail3
Stock-Based Compensation (Detail) - Weighted Average Assumptions To Estimate The Fair Value Of Equity Awards (Performance-based restricted stock units with a market condition, USD $) | 9 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Performance-based restricted stock units with a market condition | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Risk-free rate | 1.11% | 0.59% |
Expected volatility | 48.00% | 53.00% |
Grant date fair value | $7.47 | $6.39 |
Income_Taxes_Income_Taxes_Deta
Income Taxes Income Taxes (Details) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Income Tax Disclosure [Abstract] | ' | ' | ' | ' |
Effective tax rate | 37.00% | 37.00% | 37.00% | 37.00% |
RelatedParty_Transactions_Deta
Related-Party Transactions (Detail) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | |
Related Party Transactions [Abstract] | ' | ' | ' | ' | ' |
Subscription fee revenue from related party transaction | $2,200,000 | $1,300,000 | $6,500,000 | $3,800,000 | ' |
Receivables due from related parties | $0 | ' | $0 | ' | $4,400,000 |
Segment_Reporting_Detail
Segment Reporting (Detail) | 9 Months Ended |
Sep. 30, 2014 | |
segment | |
Segment Reporting [Abstract] | ' |
Number of reportable segments | 1 |
Segment_Reporting_Detail_Reven
Segment Reporting (Detail) - Revenue By Location (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Total revenue | $65,407 | $58,554 | $191,588 | $177,229 |
Total revenue | 100.00% | 100.00% | 100.00% | 100.00% |
United States | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
United States | 65.00% | 61.00% | 63.00% | 61.00% |
Total revenue | 42,751 | 35,842 | 120,696 | 108,445 |
Japan | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Other foreign country | 14.00% | 16.00% | 15.00% | 17.00% |
Total revenue | 9,164 | 9,531 | 28,012 | 29,623 |
Other | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Other foreign country | 21.00% | 23.00% | 22.00% | 22.00% |
Total revenue | $13,492 | $13,181 | $42,880 | $39,161 |
Segment_Reporting_Detail_Longl
Segment Reporting (Detail) - Long-lived Asset Information By Location (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Long-lived assets | $4,214 | $4,667 |
United States | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Long-lived assets | 4,198 | 4,646 |
Japan | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Long-lived assets | $16 | $21 |